Department of Senology, Kliniken Essen-Mitte
Essen, 45136, Germany
NCT Number: NCT02276404
Breast cancer surgery is associated with presurgical psychological distress and clinically significant side effects including postsurgical pain, nausea and fatigue. A few studies have examined how to intervene to assist women undergoing breast cancer surgery. For example presurgical hypnosis has been proven to decrease side effects and even intraoperative anesthesia use. Besides the more psychologically based interventions there are a few studies suggesting positive effects of acupuncture on pain, anxiety and nausea in surgery patients.This study aims to investigate whether a presurgical relaxation training, acupuncture treatment or a combination of both therapies is able to reduce presurgical psychological distress an postsurgical side effects in breast cancer patients in comparison to usual care.
Looking for future studies?
Notify Me18 year–75 year
Female
Interventional
Not applicable
Essen, 45136, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The relaxation sessions comprise an introduction in 3 relaxation techniques conducted by a mind-body therapist: "Body Scan", mindfulness meditation and imagination. Patients also receive a CD with different relaxation exercises and the instruction to exercise daily at home for at least 15 minutes.
The acupuncture treatment comprises needling of 6 standardized acupoints: Pericardium 6, Stomach 36, Large intestine 4, Spleen/Pancreas 10, Dumai 20, Liver 3, Shenmen. Additional points can be chosen individual.
Time frame: expected average of 13 days
Measured by 100mm visual analog scale 1 day pre surgery
Time frame: expected average of 15 days
Measured by 100mm visual analog scale 1 day post surgery
Time frame: expected average of 15 days
Measured by 100mm visual analog scale 1 day post surgery
Time frame: expected average of 21 days
Measured by 100mm visual analog scale 1 week post surgery
Time frame: expected average of 21 days
Measured by 100mm visual analog scale 1 week post surgery
Time frame: expected average of 15 days
Measured by 100mm visual analog scale 1 day post surgery
Time frame: expected average of 21 days
Measured by 100mm visual analog scale 1 week post surgery
Time frame: expected average of 15 days
Measured by 100mm visual analog scale 1 day post surgery
Time frame: expected average of 21 days
Measured by 100mm visual analog scale 1 week post surgery
Time frame: expected average of 14 days
intraoperative analgesia use is taken from operative logs
Time frame: expected average of 14 days
intraoperative anesthesia use is taken from operative logs
Time frame: expected average of 15 days
postoperative analgesia use is taken from medical records
Time frame: expected average of 14 days
natural killer cell activity is measured at begin of surgery
Time frame: expected average of 14 days
natural killer cell activity is measured at end of surgery
Time frame: expected average of 21 days
Number of patients with adverse events are measured one week post surgery
Time frame: expected average of 13 days
Measured by Profile of Mood States (POMS) 1 day pre surgery
Time frame: expected average of 15 days
Measured by Profile of Mood States (POMS) 1 day post surgery
Time frame: expected average of 21 days
Measured by Profile of Mood States (POMS) 1 week post surgery
Universität Duisburg-Essen
Other
Entspannung Und Akupunktur Zur Reduktion Perioperativer Symptome Bei Brustkrebspatientinnen- Eine Randomisiert-kontrollierte Interventionsstudie im Kontext Einer Integrativ Onkologischen Versorgung (EARpeS)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01251900
Breast Diseases, Breast Neoplasms
Lubbock, Texas, United States
View Trial DetailsNCT03314688
Breast Diseases, Breast Neoplasms
New Haven, Connecticut, United States
View Trial DetailsNCT04572295
Acrocephalosyndactylia, Bone Diseases
Nagoya, Aichi-ken, Japan
View Trial DetailsNCT07096024
Breast Diseases, Breast Neoplasms
New York, United States
View Trial Details